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scotch tape (sco) is a zebraﬁsh cardiac mutant initially proposed to exhibit a reduced amount of cardiac
jelly, the extracellular matrix between the myocardial and endocardial layers. We analyzed scote382
mutant hearts in detail using both selective plane illumination microscopy (SPIM) and transmission
electron microscopy (TEM), and observed a fascinating endocardial defect. Time-lapse SPIM imaging of
wild-type and mutant embryos revealed signiﬁcant and dynamic gaps between endocardial cells during
development. Although these gaps close in wild-type animals, they fail to close in the mutants,
ultimately leading to a near complete absence of endocardial cells in the atrial chamber by the heart
looping stage. TEM analyses conﬁrm the presence of gaps between endocardial cells in sco mutants,
allowing the apparent leakage of cardiac jelly into the lumen. High-resolution mapping places the
scote382 mutation within the fbn2b locus, which encodes the extracellular matrix protein Fibrillin 2b
(OMIM ID: 121050). Complementation and further phenotypic analyses conﬁrm that sco is allelic to puff
daddygw1 (pfdgw1), a null mutant in fbn2b, and that scote382 is a hypomorphic allele of fbn2b. fbn2b
belongs to a family of genes responsible for the assembly of microﬁbrils throughout development, and
is essential for microﬁbril structural integrity. In scote382 mutants, Fbn2b is disabled by a missense
mutation in a highly conserved cbEGF domain, which likely interferes with protein folding. Integrating
data obtained from microscopy and molecular biology, we posit that this mutation impacts the rigidity
of Fbn2b, imparting a structural defect that weakens endocardial adhesion thereby resulting in
perforated endocardium.
& 2012 Published by Elsevier Inc.Introduction
Vertebrate cardiac morphogenesis is a complex and dynamic
process, during which cells differentiate, migrate, and merge to form
the ﬁrst functional organ. The embryonic vertebrate heart is com-
posed of an outer layer of myocardial cells (cardiomyocytes), an inner
layer of endocardial cells, and an extended acellular matrix, the
cardiac jelly, separating the two layers (Nakamura and Manasek,
1981). Preceding differentiation, cardiac progenitors lie in bilateral
ﬁelds, where they receive inductive signals that modulate their fate.
In zebraﬁsh, the bilateral populations merge at the midline to form a
cone of cardiomyocytes, which then develops into the heart tube
(Stainier et al., 1993). In the heart tube, endocardial precursors spread
to form the endothelial lining of the myocardial cylinder. By 22 hours
post-fertilization (hpf), the heart starts contracting and by 24 hpf,
circulation begins. The heart undergoes looping morphogenesis byElsevier Inc.
& Biophysics 1550 4th St,
3 892.
nier).36 hpf, a process which clearly delineates atrial and ventricular
chambers (reviewed by Stainier (2001)).
The extracellular matrix plays critical roles during multiple
stages of heart development (Mjaatvedt et al., 1998; Camenisch
et al., 2000; Walsh and Stainier, 2001; Trinh and Stainier, 2004;
reviewed by Lockhart et al. (2011)). Forming a structural lattice,
the extracellular matrix organizes tissues by both providing a
physical framework and regulating the spatiotemporal availabil-
ity of signaling molecules (reviewed by Ramirez et al. (2004)).
A ubiquitous component of the extracellular matrix is provided by
the family of ﬁbrillins, large glycoproteins that aggregate to form
microﬁbrils. Microﬁbrils are ultrastructurally described as
10–12 nm diameter ﬁbrils that exhibit a beaded appearance
(Sakai et al., 1986).
In zebraﬁsh, the ﬁbrillin family consists of at least three mem-
bers, ﬁbrillin-1 (fbn1) (GenBank ID: 100330961), ﬁbrillin-2a (fbn2a)
(GenBank ID: 558217) and ﬁbrillin-2b (fbn2b) (GenBank ID: 571786).
fbn1 was targeted using morpholinos, and these studies implicated
Fbn1 in vascular development (Chen et al., 2006). A presumed null
mutation in fbn2b, pfdgw1, leads to severe notochord and ﬁn defects,
with fbn2b expression detected by whole mount in situ hybridiza-
tion in the notochord, somites, caudal vein, eye, hypochord, and
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exhibit spatiotemporally discrete expression patterns, but have
overlapping roles in morphogenesis, with Fbn1 able to compensate
for the lack of Fbn2, but Fbn2 unable to compensate for the lack of
Fbn1 in post-embryonic stages (Zhang et al., 1995; Carta et al.,
2006). In humans, mutations in FBN1 and FBN2 are the source of
Marfan syndrome (MFS, OMIM ID: 154700) and congenital contrac-
tural arachnodactyly (CCA, OMIM ID: 121050), respectively. MFS
manifests in several tissues, including ocular, skeletal and muscular
tissues, with potentially lethal cardiac defects such as aortic
aneurysm. CCA is most apparent in limbs, with transient joint
contractures and bilateral syndactyly; congenital heart disease has
also been described in CCA patients (Viljoen, 1994). The role of
signaling molecules has been highlighted in disease progression for
both MFS and CCA, with disrupted TGFß and BMP signaling
contributing to both conditions (Neptune et al., 2003; reviewed by
Ramirez et al. (2004) and Sengle et al. (2008). Fibrillins play several,
sometimes opposite, roles in TGFß signaling. These roles include
concentrating cytokines at sites where they support developmental
steps as well as sequestering latent cytokines, thereby inhibiting
their activity during postnatal tissue homeostasis (reviewed by
Dietz, 2010). FBN2 deﬁciency triggers syndactyly by failing to
concentrate BMP7 (Arteaga-Solis et al., 2001), while it promotes
osteoporosis by improper activation of latent TGFß (Nistala et al.,
2010).
Identiﬁed in a large-scale genetic screen (Chen et al., 1996),
the mutant scotch tape (sco) exhibits by both a ﬁn fold phenotype
and a heart defect. We employed selective plane illumination
microscopy (SPIM) (Huisken et al., 2004) on live animals to
analyze endocardial development in this mutant. Using ﬂuores-
cent transgenic ﬁsh lines, SPIM allowed us to reveal the dynamic
nature of endocardial development and dissect the novel impact
of the sco mutation on endocardial sheet continuity. Using
positional cloning, we show that scote382 is a hypomorphic allele
of fbn2b, thereby revealing the key role of this molecule in a
discrete aspect of heart development.Materials and methods
Zebraﬁsh strains
All embryos and adults were raised and maintained as described
in Westerﬁeld (2000). The following mutants and transgenic lines
were used: scote382 (Chen et al., 2006); pfdgw1 (Anderson et al.,
2007); Tg(kdrl:GFP)s843 (Jin et al., 2005), to mark endothelium;
Tg(my17:DsRed)s879 (Chi et al., 2008) to mark myocardium. The
scote382 mutant line was obtained from the Max Planck Institute in
Tu¨bingen and outcrossed several times before analysis.
Morpholino injections
Morpholino oligonucleotides were diluted with water and phe-
nol red and injected into one-cell stage embryos. We injected 2 ng
of cardiac troponin T type 2 (tnnt2) start site targeted morpholino
(50-CATGTTTGCTCTGATCTGACACGCA-30 (Sehnert et al., 2002)) and
0.8, 1.6, and 2.4 ng of ﬁbrillin-2b (fbn2b) start site targeted morpholino
(50-GCGACTCCTGAAGCGCCGGTAAATG-30 (Gansner et al., 2008)).
Live imaging
Embryos and larvae were imaged using multidirectional selec-
tive plane illumination microscopy (mSPIM). Animals were
embedded in low-melt agarose and consecutively imaged every
2 min for up to 12 h, as commonly done in SPIM (Huisken and
Stainier, 2009). A 488 nm laser (Coherent Sapphire) was used toexcite ﬂuorescence in Tg(kdrl:GFP) ﬁsh. 3D stacks of images were
recorded using an EM-CCD camera (Andor). To visualize the time-
lapse data, maximum intensity projections were computed for the
ventral half of the heart using Matlab. For dual color high-speed
movie recordings, double transgenic (kdrl:GFP and my17:DsRed)
embryos were imaged using simultaneous illumination with 488
and 561 nm and detected with two EM-CCD cameras (Scherz
et al., 2008). Differential interference contrast (DIC) microscopy of
48 hpf Tg(kdrl:GFP) embryos was conducted with a Nikon Eclipse
TE300, using a CoolSNAP ES2 camera and processed with Meta-
Morph software. Embryos were sedated with tricaine, and
embedded in low-melt agarose.
Electron microscopy
Embryos were ﬁxed with 0.8% paraformaldehyde/2.5% glutar-
aldehyde in 0.1 M Cacodylate buffer at 4 1C overnight at 30 hpf.
The samples were processed and stained at the Pathology &
Imaging Core of the Liver Center at the University of California,
San Francisco.
Genetic mapping
Heterozygote carriers of the scote382 allele were crossed to India
ﬁsh to establish mapping lines. This mutation had previously been
assigned to chromosome 22 (Geisler et al., 2007). We used 576
mutant embryos for ﬁne mapping and reduce the candidate region.
Using both previously published SSLP markers (Knapik et al., 1998)
and markers designed using the zebraﬁsh SSR search site of the
Massachusetts General Hospital (http://danio.mgh.harvard.edu/
userMarkers/usrInputSsr.html), we were able to deﬁne a critical
region ﬂanked by two recombinants on one side and one on the
other. The 8.6 kb fbn2b cDNA was cloned in its entirety using
Superscript III reverse transcriptase (Invitrogen) and Phusion DNA
polymerase with high-ﬁdelity buffer (Finnzymes), using the follow-
ing primer sequences: 50-AGGGTGAGGCACATTTACCG-30 (forward)
and 50-GTGTCTTCACACTCGTCGATG-30 (reverse) (Gansner et al., 2008),
and subsequently sequenced using internal primers.Results
The scote382 mutation causes pericardial edema and adhesion defects
in the dorsal and ventral ﬁn folds
The ﬁrst visible defects exhibited by scote381 mutants are
pericardial edema and deformed ﬁn folds. The malformed caudal
ﬁns are ﬁrst observed by 24 hpf. The ﬁn folds fail to develop
properly, exhibiting a ragged, truncated appearance (Fig. 1A and
B). This phenotype is present in all mutant embryos, but does not
seem to affect overall ﬁtness. By 48 hpf, the mutant ﬁn fold
phenotype is more pronounced and is frequently accompanied by
pericardial edema (Fig. 1C and D). To understand the cause of
pericardial edema, we examined the heart at higher magniﬁcation
and observed an apparent loss of endocardium at the outer
curvature of the atrium (Fig. 2), a previously unreported pheno-
type. At low magniﬁcation under transmitted light, blood cells
appear to come in direct contact with the atrial myocardium
(Chen et al., 1996) unlike in wild-type hearts where a layer of
cardiac jelly in addition to the endocardium provides a barrier
between the two. Wild-type embryos maintain a substantial layer
of cardiac jelly, while mutant embryos appear to lose this layer.
Stills taken from live imaging movies (Movies S1, S2) document
the loss of endocardial cells, as assessed by the kdrl:GFP reporter
(Fig. 2C and D). Further, DIC microscopy shows gaps in the
endocardial sheet (Fig. 2E–G). These observations indicate that
24 hpf wt
24 hpf sco -/-
48 hpf wt
48 hpf sco -/-
Fig. 1. The scotch tape phenotype includes both a ﬁn and a heart defect. Transmitted light images (A)–(D) show that the scote382 phenotype is visible by 24 hpf (A) and
(B) and becomes clearer by 48 hpf (C) and (D). The caudal and dorsal ﬁn fold defects manifest as a failure of the ﬁn folds to expand, leading to a jagged appearance ((B), (D),
black arrows) when compared to wild-type siblings (A) and (C). The heart defect can be accompanied by pronounced pericardial edema ((D), white arrow). Scale bars:
(A) and (B), 0.5 mm; (C) and (D): 1 mm.
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other. Despite this phenotype, ﬂow is largely unperturbed through-
out the vasculature, which otherwise appears unaffected (Fig. 2A
and B). This fully penetrant endocardial phenotype is accompanied
by signiﬁcant pericardial edema in approximately one-third of the
homozygous mutant animals (n4500 mutant embryos examined).
This mutation is usually lethal by 120 hpf when both heart
phenotypes are present. The incomplete penetrance of the peri-
cardial edema phenotype may be due to the variable severity of the
endocardial defect, which ranges from holes in the outer curvature
of the atrium to a complete loss of atrial endocardium. Thus,
animals with a higher degree of endocardial loss may be more
prone to developing defects in cardiac function, exhibit pericardial
edema and die during larval stages. When pericardial edema is
absent, as is the case in approximately two-thirds of the homo-
zygous mutants, many individuals (32o52) survived until at least
two months of age.
The scote382 mutation disrupts endocardial formation in the atrium
To better understand the cause of the endocardial defects in
sco mutants, we carried out live imaging analyses. Intriguingly,
these studies revealed transitory gaps in the endocardium of both
wild-type and mutant atria at 48 hpf (Fig. 3). Projections of
z-stacks taken with SPIM conﬁrmed the presence of these endo-
cardial gaps. In wild-type embryos, gaps form and non-direction-
ally ‘‘migrate’’ before closing to form a continuous endocardial
sheet (Fig. 3D, Movie S3). Time-lapse SPIM studies were facili-
tated by the use of a tnnt2 morpholino to halt heart contractions
(Sehnert et al., 2002), thereby allowing imaging of the entireatrium. tnnt2 morphants have no blood ﬂow, but exhibit appar-
ently normal endocardial morphogenesis in the atrium during the
investigated period of 36–48 hpf. The transient gaps observed in
wild-type atria were also observed in scote382 mutants. However,
in these animals, an additional type of gap emerged and failed to
close (Movie S4). A prominent hole in the endocardial layer
usually formed at the outer curvature of the atrium, opposite
the inﬂow tract in both uninjected and tnnt2 morpholino injected
scote382 homozygous mutant embryos (Fig. 3B and C, E and F).
These data suggest that blood ﬂow is not necessary for the loss of
atrial endocardial cells in sco mutants.
Endocardial development is a dynamic process
Our in vivo imaging provided the opportunity to follow endocar-
dial morphogenesis during heart tube formation in real time. SPIM
provides high spatial and temporal resolution with minimal photo-
toxicity (Huisken and Stainier, 2009), and allowed us to document the
progression of endocardial cells in real-time throughout the entire
heart. In both wild-type and sco mutant hearts, there was rapid,
largely non-directional endocardial cell migration (Movies S3 and S4).
During this process, the formation of gaps could be observed at the
junction between three cells, in both wild-type and mutant embryos.
These transitory holes (Fig. 4, indicated by arrows) rapidly moved
throughout the documented period of 36–48 hpf, comparable to the
speed of overall cell migration. In addition to their movement, the
gaps themselves were temporary, both forming and closing during
this period. In scote382 mutants, a second type of endocardial hole
evolved, which likely contributed to a permanent endocardial deﬁ-
ciency (Fig. 4, outlined). These holes initially occupied the space
0.5 mm
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Fig. 2. Heart vasculature defects in scote382 mutants. Fluorescence images of 72 hpf Tg(kdrl:GFP)s843 wild-type (A) and scote382 mutant (B) larvae. The overall patterning of
the vasculature appears unaffected in scote382 mutant larvae; however, pronounced pericardial edema (black arrow in panel A) indicates a severe defect in heart function.
Closer inspection reveals the absence of endocardial cells in the mutant atrium (white arrow in panel B). SPIM images show Tg(kdrl:GFP)s843; Tg(my17:DsRed)s879 wild-type
endocardium and myocardium (C) at 48 hpf and the Tg(kdrl:GFP)s843 scote382 mutant atrium, which appears to lack its endocardial lining (D) at 72 hpf. Panels C and D are
stills taken fromMovies S1 and S2, respectively. Panels E–G are DIC images of a scote382 mutant atrium taken at 40 . An endocardial cell (white arrow) fails to adhere to its
neighbor, thereby creating a gap (white arrowhead) in the endocardial sheet; DIC (E), the endothelial kdrl:GFP reporter (F) and merged image (G). A: atrium; V: ventricle.
K. Mellman et al. / Developmental Biology 372 (2012) 111–119114opposite the inﬂow tract. Thus, our SPIM analyses suggest that sco is
required for endocardial sheet integrity/continuity.
Electron microscopy studies conﬁrm defects in the endocardial layer
Electron microscopy studies conﬁrmed structural weaknesses
in the endocardial layer. In wild-type samples (Fig. 5A, C, E),
endocardial cells form an unbroken barrier between the cardiac
jelly and the cardiac lumen. This barrier is sufﬁcient to contain
the cardiac jelly between the myocardium and endocardium, and
lines the entire heart. In contrast, the mutant endocardium
(Fig. 5B, D, F) displayed deﬁcient cell–cell contacts. Examination
at increasing magniﬁcation clearly shows that these contacts are
defective, and reveals gaps between endocardial cells. By failing
to sufﬁciently adhere to each other, endocardial cells generate a
layer that fails to form an unbroken barrier between the myo-
cardium and endocardium. Gaps between endocardial cells in the
mutant atria seem to allow the leakage of cardiac jelly into the
cardiac lumen (Fig. 5B, D, F).
scote382 corresponds to ﬁbrillin-2b
To begin to understand the mechanisms leading to the endocar-
dial defects in the scomutant hearts, we sought to identify the geneaffected by the scote382 mutation. The scote382 mutation had pre-
viously been assigned to chromosome 22 (Geisler et al., 2007). Using
established as well as newly developed polymorphic markers, we
were able to map the mutation to an interval of approximately
0.5 cM. One of the ﬂanking markers was designed from sequence in
the CH211-124A3 BAC, while the ﬂanking marker on the other side
of the mutation was SSLP z33723, which lies on the ZFOS-412G11
fosmid (Fig. 6A). In this region lie several genes, including tim44,
ticam1, kdm4b and fbn2b. fbn2b has a null allele, pfdgw1, which has
been reported to have signiﬁcant notochord and ﬁn defects
(Gansner et al., 2008). Because of the similarity of the pfdgw1
and scote382 ﬁn defects, we decided to test whether these muta-
tions affect the same gene. Indeed, we found that pfdgw1 failed to
complement scote382, indicating that scote382 is an allele of fbn2b
(Fig. S7). In embryos obtained from heterozygote pfdgw1 to hetero-
zygote scote382 crosses, 23% (145 embryos examined from multiple
crosses) exhibited pericardial edema as well as a very defective
caudal ﬁn fold with a blistered appearance, phenotypes more similar
to those observed in pfdgw1 than in scote382 mutants. The lack
of complementation, as well as the decreasing severity of the
caudal ﬁn fold phenotype as one goes from pfdgw1 homozygous
mutants, pfdgw1/scote382 heteroallelic mutants to scote382
homozygous mutants, indicate that scote382 is a hypomorphic
allele of fbn2b.
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Tg(kdrl:GFP)
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Fig. 3. The endocardium fails to line the entire atrium in scote382 mutants. SPIM images of 48 hpf Tg(kdrl:GFP)s843; Tg(my17:DsRed)s879 embryos. Wild-type endocardium (A),
(D) forms transient gaps, but recovers to line the entire chamber. A transient gap is outlined in white in panel D. The cardiac jelly (CJ) layer remains intact. scote382 mutant
endocardial cells form transient gaps that develop into large areas devoid of endocardial cells (B), (C), (E) and (F). Endocardial gaps form in both the presence
(A)–(C) and absence (D)–(F) of blood ﬂow. Images taken in the presence of ﬂow (A)–(C) are stills taken from movies documenting beating hearts (Movies S5 and S6). tnnt2
MO injected embryos (D)–(F) exhibit the same pattern of transient gaps in wild-type and scote382 mutants, with a stereotypical deﬁciency in the outer curvature of the
atrium observed in mutants. A: atrium; V: ventricle. Scale bar: 20 mm.
Tg(kdrl:GFP)
163/841163/13
163/562163/481
20 µm
Fig. 4. Endocardial cells form gaps during development, with a permanent
deﬁciency manifesting in scote382 mutants. The mutant endocardium forms
transient gaps, with a stable and permanent gap developing initially in the outer
curvature of the atrium. Stills taken from a time-lapse SPIM movie (Movie S4) of
one embryo document dynamic endocardial behavior in a tnnt2 MO injected
kdrl:GFP scote382 mutant heart between 36 and 48 hpf. Frame number (n/361) is
recorded in the bottom left corner of each panel. Red arrows point to transitory
gaps, with gaps contributing to permanent holes outlined in red. In panels B, C and
D, the larger outlined gap is in a proximal focal plane, with the smaller gap
residing in the far wall of the atrium. Transitory gaps often form at the junction
between three cells. Expected boundary of the atrial endocardial layer is indicated
by the white dashed line.
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phenotype
In order to further test the hypothesis that a mutation in the
fbn2b gene is responsible for the scote382 phenotypes and poten-
tially gain additional insight into the endocardial phenotype, we
sequenced the fbn2b cDNA from scote382 mutants. This analysis
identiﬁed a missense mutation in a calcium-binding epidermal
growth factor (cbEGF) domain (Pereira et al., 1993), which leads
to the substitution of a conserved cysteine by phenylalanine. This
highly conserved region is essential for the overall structure
(Reinhardt et al., 1997) and rigidity (Werner et al., 2000) of all
ﬁbrillins. Other polymorphisms detected include a glutamine
substituted for a lysine at the very end of the protein, as well as
a serine substituted for a phenylalanine in a TGF-ß binding (TB)
domain. The substitution at the end of the sequence is in a region
with no assigned domain, and is unlikely to affect overall func-
tion. The TB domain substitution of a large, nonpolar amino acid
with a small, uncharged polar amino acid is unlikely to disrupt
protein structure or function signiﬁcantly, particularly when
considering the predicted lesser contribution of this conserved
TB domain to overall structure and function. Further, cysteine
substitutions in cbEGF domains are the most common source of
ﬁbrillin mutants in humans (Collod-Beroud et al., 2003), strongly
indicating that the cysteine to phenylalanine change in Fbn2b is
responsible for the scote382 phenotype.Discussion
In vivo SPIM imaging allowed us to illuminate the dynamic nature
of endocardial cell development between 36 and 48 hpf at single cell
resolution. While the endocardial deﬁciency in scote382 mutants is
visible by other microscopy techniques, SPIM allowed us to chart the
progression of individual cells, as well as detect transitory gaps in the
endocardium, in both wild-type and mutant embryos, which had not
been described previously. Further, this dynamic nature of cell–cell
contact is something we observed only in the endocardial layer, and
1 m
2 m
wt
wt
sco -/-
sco -/-
1 m
2 m
sco -/-wt
Fig. 5. Electron microscopy study of endocardium details adhesion defects. Sections of 30 hpf wild-type (A), (C), (E) and scote382 mutants (B), (D), (F) at 9.4 kX (A) and
(B) and 19 kX (C) and (D). Panels E and F correspond to the boxed areas of C and D, respectively. Wild-type endocardial cells (A), (C), (E) form a continuous layer between
the cardiac jelly and the cardiac lumen. Mutant cells (B), (D), (F) fail to adhere to each other leading to a disorganized barrier, and allowing cardiac jelly to leak into the
lumen. In (B), (D) and (F), the lumen and blood cells are located in the upper-left, while space between the endocardium and myocardium (which the cardiac jelly should
occupy) is in the lower-right. Black arrows point to breaks between endocardial cells. CJ: cardiac jelly; BC: blood cell; L: lumen.
K. Mellman et al. / Developmental Biology 372 (2012) 111–119116not in the myocardial layer. A mutation in fbn2b disrupts an
important structural and signaling extracellular protein, resulting in
a novel cardiac defect characterized by the signiﬁcant loss of
endocardial cells speciﬁcally in the atrium.
Several lines of evidence indicate that sco corresponds to fbn2b,
including the failure of scote382 and pfdgw1 to complement. While there
is a possibility of non-allelic non-complementation, it is unlikely due
to the nearly complete penetrance of the non-complementation
between scote382 and pfdgw1, as well as the presence of fbn2b in the
critical region, whichwe narrowed down to a relatively small interval.
Further, the caudal ﬁn fold phenotype observed in scote382 mutants is
manifest in the null fbn2b mutant, albeit in a more severe form.
The location of the scote382 lesion in a highly conserved cbEGF
domain raises the question as to whether it affects the whole
protein or only one of its domains. As the scote382 endocardial
phenotype was not reported in previous analyses of fbn2b mutants
(Gansner et al., 2008), its existence suggested the possibility of the
scote382 mutation as a neomorphic, rather than a hypomorphic,
fbn2b allele. To address this question, we injected low amounts of
fbn2b morpholino in an effort to phenocopy the scote382 mutation,
and indeed observed a scote382-like endocardial phenotype in
approximately 65% of the embryos injected with 0.8 ng of fbn2b
morpholino. Further, the distinctive endocardial phenotype
observed in scote382 mutants can also be seen in pfdgw1 mutants,
as evidenced by blood cells seemingly coming into contact with the
myocardium (data not shown). Altogether, these data indicate that
scote382 is a hypomorphic, rather than a neomorphic, allele of fbn2b.
All ﬁbrillins contain highly conserved, repeating modular
domains that include a calcium-binding epidermal growth factor-
like (cbEGF) domain as well as a novel 8 cysteine motif (TB/8-cys)domain. The binding of calcium provides the main strength behind
ﬁbrillin stabilization, by arranging the cbEGF domains into a rigid
linear structure (Reinhardt et al., 1997). Each cbEGF domain
includes six cysteine residues posited to form three disulﬁde bonds
(Handford et al., 2000). The scote382 lesion affects the 16th cbEGF
domain, substituting a cysteine with a phenylalanine. Over 400
different mutations in FBN1 have been associated with MFS and
related disorders in humans (Collod-Beroud et al., 2003). The high
degree of amino acid similarity between human FBN1 and zebra-
ﬁsh Fbn2b (67%) (Gansner et al., 2008), particularly with respect to
conserved domains, led us to use the documented FBN1 mutations
as a model for investigating the fbn2b polymorphisms in scote382.
Using the extensively studied mutations in FBN1 cbEGF domains as
a model, we propose that the failure of Fbn2bte382 to properly fold a
cbEGF domain impacts overall protein localization and/or stability
(Whiteman et al., 2006). Three disulﬁde bonds are required to
maintain native cbEGF folds, with mutations of cysteine in con-
served regions impairing trafﬁcking of FBN1 (Johnson and Haigh,
2000; Collod-Beroud et al., 2003).
The instability of Fbn2b caused by the scote382 mutation could be
responsible for the endocardial phenotype through the failure of
the immediate supporting matrix, the failure to regulate signaling
molecules, or a combination of the two. Proper adhesion between
endocardial cells requires support from surrounding extracellular
matrices (reviewed by Geiger et al. (2009)). Improperly folded
or trafﬁcked Fbn2b could lead to a lack of structural integrity,
and thereby contribute to the formation of the large gap in the
endocardial sheet in the outer curvature of the atrium.We originally
thought that this stereotypical localization of the gap was the result
of endocardial cells ‘‘sloughing off’’ due to the high force of blood
Fig. 6. The scote382 mutation is in the ﬁbrillin 2b (fbn2b) gene on linkage group 22. High-resolution mapping, using 576 mutant embryos, placed this mutation in a region
containing 2 overlapping BAC clones (CH211-124A3, CH211-52O10), a gap of unknown size, and 1 fosmid clone (ZFOS-412G11), with red asterisks indicating ﬂanking
markers (A). Sequencing data identiﬁed a missense mutation substituting a guanine for a thymine at nucleotide 3935 ((E); indicated with red). Sequencing traces show
wild-type sequence with a guanine (C); mutant sequence has a thymine instead of a guanine (D). The sequence for the exon containing this mutation is listed in panel E.
This mutation changes a cysteine to a phenylalanine at amino acid 1313 in a cbEGF domain ((B), indicated by a red arrow); this cysteine is highly conserved between cbEGF
domains within the protein, as well as between vertebrates ((F); affected amino acid indicated by red arrow). Dashed rectangle: EGF-like domain; dashed oval: hybrid
motif; black rectangle: glycine-rich domain; white rectangle: cbEGF domain; white oval: TB domain.
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absence of blood ﬂow. This region experiences a period of rapid
growth, during which an extracellular matrix composed of defective
microﬁbrils, as in scote382 mutants, may fail to form and expand
sufﬁciently to ensure endocardial cell adhesion.
Signaling defects may also play a signiﬁcant role in the
endocardial phenotype of scote382 mutants. BMP signaling is known
to be disrupted in Fbn2 null mice (Arteaga-Solis et al., 2001),
particularly with respect to digit formation. BMP-7 has been
documented to accumulate on ﬁbrillin-rich microﬁbrils (Gregory
et al., 2005), and thus a disorganized extracellular matrix, such as
the scote382 mutant matrix, could interfere with BMP signaling.
TGFß signaling plays a dominant role in the aortic aneurysms
observed in FBN1 mutant carriers. In wild-type individuals, the
extracellular matrix serves to sequester TGFß and effectively
inhibit its activation. Defects in the extracellular matrix, espe-
cially in the form of mutated FBN1, result in excessive TGFß
signaling (Neptune et al., 2003). The high degree of amino acid
similarity between FBN1 and FBN2 suggests that FBN2 could
exhibit similar interactions with TGFß. In addition to canonical
Smad-dependent TGFß signaling, TGFß can activate non-canoni-
cal pathways, with recent observations indicating non-canonicalsignaling as the main driving force behind MFS disease progres-
sion (Holm et al., 2011). Strong evidence for this hypothesis is
seen with the treatment of MFS mice with TGFß-neutralizing
antibodies (Neptune et al., 2003), as well as the angiotensin II
type 1 receptor blocker Losartan, both of which reduce the
amount of active TGFß and ameliorate symptoms (Cohn et al.,
2007). Treatments using CMK, an inhibitor of a protease required
for TGFß processing, or Losartan failed to rescue scote382 mutants,
potentially indicating that excess TGFß signaling does not cause
the observed phenotypes, although further investigation into
these pathways is warranted. Given the highly dynamic nature
of endocardial behavior during the stages when the scote382
phenotype ﬁrst emerges as well as the dramatic consequences
that are likely to occur on the signaling state of the cells as they
lose adhesion with their neighbors, new tools will be required to
understand how Fbn2b regulates endocardial morphogenesis.
There are several interesting questions posed by the endocar-
dial phenotype of scote382 mutants. First, why is it restricted to the
atrium? Potential insight into this query can be gained from several
observations including the absence of trabeculation in the atrium.
Trabeculation is the process by which cardiomyocytes extend into
the lumen of the ventricle, forming organized muscle sheaths
K. Mellman et al. / Developmental Biology 372 (2012) 111–119118required for heart function (Ben-Shachar et al., 1985; Gassmann
et al., 1995; Lee et al., 1995; Liu et al., 2010). Perhaps the stress
placed on ventricular endocardial cells by the forming trabeculae
require different or more signiﬁcant cell–cell adhesions as com-
pared to atrial endocardial cells. Potentially related to the trabe-
culation process is the difference in the behavior of the ventricular
and atrial endocardial cells. Whereas ventricular endocardial cells
are closely apposed to the cardiomyocytes, the atrial endocardial
cells are separated from the cardiomyocytes by a substantial layer
of cardiac jelly (Scherz et al., 2008; Liu et al., 2010). Consequently,
when the chambers contract, the atrial endocardial cells undergo
more signiﬁcant movement and deformation, which are likely to
put their cell–cell junctions under considerable stress. Another
interesting question lies in the precise cause of cardiac dysfunc-
tion: why does the lack of atrial endocardial cells cause cardiac
dysfunction while animals that lack atrial contractions survive
(Berdougo et al., 2003)? It is likely that the Fbn2b defect in scote382
mutants also affects cardiomyocyte maturation and function in
more subtle ways than it affects the endocardial cells.4. Conclusions
This study documents the effects of a hypomorphic fbn2b muta-
tion in zebraﬁsh, most notably the formation of gaps in the atrial
endocardial sheet. High-resolution live imaging reveals the dynamic
nature of endocardial cells at this stage, with EM imaging conﬁrming
breaks between the cells in the mutant hearts. We hypothesize that
the nucleotide substitution in scote382 mutants impacts the overall
structure of Fbn2b, resulting in endocardial cells that fail to adhere to
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